Biaggioni was new to me, so I looked him up, and just by his last three studies I am so excited. Just look!
Orthostatic Hypotension and Cardiovascular Risk.
Shibao C, Biaggioni I.
Hypertension. 2010 Nov 8. [Epub ahead of print] No abstract available. PMID: 21059992
Long-term Treatment With Rituximab of Autoimmune Autonomic Ganglionopathy in a Patient With Lymphoma.
Hollenbeck R, Black BK, Peltier AC, Biaggioni I, Robertson D, Winton EF, Raj SR.
Arch Neurol. 2010 Nov 8. [Epub ahead of print]PMID: 21059985
Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.
Shibao C, Okamoto LE, Gamboa A, Yu C, Diedrich A, Raj SR, Robertson D, Biaggioni I.
Hypertension. 2010 Nov;56(5):847-51. Epub 2010 Sep 13.PMID: 20837887
"Orthostatic hypotension affects patients with autonomic failure producing considerable disability because of presyncopal symptoms."
http://www.ncbi.nlm.nih.gov/pubmed/20837887
Wow, isn't that cool? Just the researcher we need.
There's lots more on OI and POTS, the vanilloid receptor (haven't I heard something about that in connection to ME?), inflammation, autonomic study, and cell biology. This is a serious scientist with interests in the actual pathology areas of ME.
And looky here:
Raj V, Haman KL, Raj SR, Byrne D, Blakely RD, Biaggioni I, Robertson D, Shelton RC. "Psychiatric profile and attention deficits in postural tachycardia syndrome." J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):339-44. Epub 2008 Oct 31. PMID:
18977825
Department of Psychiatry, Vanderbilt University School of Medicine, 1500 21st Ave, South, Nashville, TN 37212, USA.
Abstract
OBJECTIVES: Patients with postural tachycardia syndrome (POTS) often appear anxious and report inattention. Patients with POTS were formally assessed for psychiatric disorders and inattention and compared with patients with attention deficit hyperactivity disorder (ADHD) and control subjects.
METHODS: Patients with POTS (n = 21), ADHD (n = 18) and normal control subjects (n = 20) were assessed for DSM-IV psychiatric disorders and completed a battery of questionnaires that assessed depression, anxiety and ADHD characteristics.
RESULTS: Patients with POTS did not have an increased prevalence of major depression or anxiety disorders, including panic disorder, compared with the general population. Patients with POTS had mild depression. They scored as moderately anxious on the Beck Anxiety Inventory but did not exhibit a high level of anxiety sensitivity. Patients with POTS scored significantly higher on inattention and ADHD subscales than control subjects. These symptoms were not present during childhood.
CONCLUSIONS: Patients with POTS do not have an increased lifetime prevalence of psychiatric disorders. Although they may seem anxious, they do not have excess cognitive anxiety. They do experience significant inattention which may be an important source of disability.